Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BlastGen

K-Number: K152932 · 2016-02-29

ApplicantOrigio A/S
Decision Date2016-02-29
Product CodeMQL
Advisory CommitteeOB
DecisionSubstantially Equivalent

Device Summary

BlastGen is a medical device manufactured by Origio A/S. It received FDA 510(k) clearance on 2016-02-29 under approval number K152932. The device is classified under product code MQL. It was reviewed by the OB advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BlastGen?

BlastGen is a medical device that received FDA 510(k) clearance on 2016-02-29. It is manufactured by Origio A/S. The 510(k) number is K152932.

When was BlastGen approved by the FDA?

BlastGen received FDA 510(k) clearance on 2016-02-29, under approval number K152932.

What company makes BlastGen?

BlastGen is manufactured by Origio A/S.

What is the FDA product code for BlastGen?

The FDA product code for BlastGen is MQL.

Other Devices by Origio A/S

View all 8 devices →

Related Devices (Code: MQL)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.